Insulin aspart, recombinant Subcutaneous and Posaconazole Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Posaconazole Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Posaconazole Intravenous
- Insulin aspart, recombinant Subcutaneous-Posaconazole Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Posaconazole oral/injection
- Insulin aspart, recombinant Subcutaneous-Posaconazole Tablets
- Insulin aspart, recombinant Subcutaneous-PosiFlush flush
- Insulin aspart, recombinant Subcutaneous-Positive Skin Test Control - Histamine
- Posaconazole Injection-Insulin degludec
- Posaconazole Injection-Insulin Degludec (U-100) Prefilled Pens
- Posaconazole Injection-Insulin Degludec (U-100) Vials
- Posaconazole Injection-Insulin Degludec (U-200) Prefilled Pens
- Posaconazole Injection-Insulin degludec and liraglutide
- Posaconazole Injection-Insulin degludec and liraglutide Subcutaneous